XSPRAY fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Xspray Pharma AB is a pharmaceutical company, which develops and produces product candidates in clinical development phase. It uses its innovative, patented technology to develop amorphous product candidates that are improved versions of marketed drugs, primarily protein kinase inhibitors, for the treatment of cancer. Its product portfolio includes candidates based on the firm's HyNap platform: Dasynoc, HyNap-Nilo, and HyNap-Sora. The company was founded by Mustafa Demirbüker and Håkan Nykvist in November 2003 and is headquartered in Solna, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
XSPRAY does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company